Sort
11,323 grants matching “glioblastoma”
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
$408,374Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2011 · NS
Targeting N-linked Glycosylation to Enhance Radiation Therapy
$408,361Joseph N Contessa · Yale University · R01 · FY2016 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$408,013Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2022 · NS
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · EB
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · EB
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · EB
Improving response to immunotherapy by genistein and antiestrogens
$407,663Leena A Hilakivi-Clarke · University Of Minnesota · R21 · FY2021 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$407,551Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Intranasal Stem-Cell Based Therapy for Glioblastoma
$407,515Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2016 · NS
Project 1: Deciphering the Dynamic Evolution of the Tumor-Neural Interface
$407,357Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2024 · CA
Mechanism of regulation of progenitor proliferation and transformation
$407,306Patrizia Casaccia · Advanced Science Research Center · R01 · FY2018 · NS
Regulation of CXCR4 by cognate and non-cognate ligands
$407,200Elias Lolis · Yale University · R01 · FY2009 · AI
RNA-Based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$407,160John H Sampson · Duke University · R01 · FY2009 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$407,147Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · NS
Determining the role of lipid droplets in glioblastoma and their therapeutic potential
$407,145Deliang Guo · Ohio State University · R01 · FY2018 · NS
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2019 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2021 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,023Sidi Chen · Yale University · R33 · FY2020 · CA
Controlled Release of Macromolecules
$407,004Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2008 · EB
Cancer stem cells and human liver cancer
$406,993Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Novel functions of Pyruvate kinase M2 in DNA double-strand break repair
$406,812Fen Xia · Univ Of Arkansas For Med Scis · R01 · FY2016 · CA
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
$406,708Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2017 · CA
IDO1 and Immunotolerance in Glioblastoma
$406,629Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2019 · NS
Controlled Release of Macromolecules
$406,614Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2009 · EB
Toxicity profiling: creating novel paradigms to personalize cancer treatment
$406,559Terri S. Armstrong · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · NR